TREND-02 - a Phase II Exploratory De-escalation Trial of Neoadjuvant Sacituzumab Govitecan Plus Tislelizumab (SG/I) in Early Triple-negative Breast Cancer
PHASE2
Refining neoadjuvant chemoimmunotherapy and establishing predictive biomark...
Body Posture, Joint Mobility, and Trunk Muscle Endurance Related to Lower Back Pain in Tennis Players
N/A
The aim of this study was to determine the significance of the impact of ex...
Status
Completed
Location
Mirai Clinic
Start Date
2022-04-01
Trial ID
NCT06890845
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.
PHASE3
Open-label, phase III, randomized, stratified (PDL1- vs PDL1+), 3 arms, mul...